1. Small cell lung cancer state-of-the-art therapy;Ihde;Chest 1995,1994
2. Docetaxel (Taxotere) in extensive stage small cell lung cancer (SCLC): a phase II trial of the southwest oncology group (SWOG);Burris;Proc. Am. Soc. Clin. Oncol.,1998
3. Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC);Cormier;Ann. Oncol.,1994
4. A phase II study of irinotecan (CPT-11) in patients (pts) with small cell lung cancer (SCLC) progressing after initial response to first-line chemotherapy (CT);Le Chevalier;Proc. Am. Soc. Clin. Oncol.,1997
5. A phase II study of paclitaxel and granulocyte colony-stimulating factor in previously untreated patients with extensive-stage small cell lung cancer: a Study of the North Central Cancer Treatment Group;Jett;Semin. Oncol.,1995